Esther Pueyo Selected Research

Myocardial Infarction

10/2004	Individual patterns of dynamic QT/RR relationship in survivors of acute myocardial infarction and their relationship to antiarrhythmic efficacy of amiodarone.
9/2004	Characterization of QT interval adaptation to RR interval changes and its use as a risk-stratifier of arrhythmic mortality in amiodarone-treated survivors of acute myocardial infarction.
9/2003	Effect of amiodarone on the descending limb of the T wave.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Esther Pueyo Research Topics

Disease

7	Cardiac Arrhythmias (Arrythmia) 04/2022 - 09/2010
5	Chronic Kidney Failure (Chronic Renal Failure) 04/2022 - 01/2021
4	Heart Failure 01/2022 - 05/2010
4	Ischemia 03/2020 - 05/2010
4	Torsades de Pointes (Torsade de Pointes) 01/2016 - 09/2010
3	Fibrosis (Cirrhosis) 02/2022 - 03/2020
3	Cardiac Sudden Death (Sudden Cardiac Arrest) 01/2022 - 01/2017
3	Myocardial Infarction 10/2004 - 09/2003
2	Inflammation (Inflammations) 01/2022 - 03/2020
2	Drug-Related Side Effects and Adverse Reactions 09/2010 - 01/2010
1	Hyperkalemia 02/2022
1	Embolic Stroke 01/2022
1	Mitochondrial Diseases (Mitochondrial Disease) 01/2022
1	Atrial Fibrillation 01/2021
1	Vascular Diseases (Vascular Disease) 01/2021
1	Ventricular Tachycardia 03/2020
1	Skin Diseases (Skin Disease) 01/2020
1	Hyperplasia 01/2020
1	Melanoma (Melanoma, Malignant) 01/2018
1	Neoplasms (Cancer) 01/2018
1	Hypotension (Low Blood Pressure) 09/2017
1	Long QT Syndrome 04/2015
1	Coronary Occlusion 05/2013
1	Stroke (Strokes) 05/2013
1	Cardiotoxicity 01/2010
1	Infarction (Infarctions) 10/2004

Drug/Important Bio-Agent (IBA)

6	PotassiumIBA 04/2022 - 01/2021
5	CalciumIBA 04/2022 - 01/2016
4	Pharmaceutical PreparationsIBA 11/2015 - 01/2010
3	Biomarkers (Surrogate Marker)IBA 01/2017 - 01/2010
3	Amiodarone (Amiodarona)FDA LinkGeneric 10/2004 - 09/2003
2	Ion Channels (Ion Channel)IBA 01/2020 - 04/2015
2	Potassium Channels (Potassium Channel)IBA 01/2016 - 04/2015
1	ElectrolytesIBA 04/2022
1	CollagenIBA 02/2022
1	Adrenergic Agents (Adrenergic Drugs)IBA 01/2021
1	3-nitrotyrosineIBA 03/2020
1	salicylhydroxamic acid (SHAM)IBA 03/2020
1	MelatoninIBA 03/2020
1	VimentinIBA 03/2020
1	CytokinesIBA 01/2020
1	senicapocIBA 01/2020
1	Interleukin-6 (Interleukin 6)IBA 01/2020
1	SodiumIBA 01/2016
1	Sodium-Potassium-Exchanging ATPase (Sodium, Potassium ATPase)IBA 02/2014
1	Sotalol (Sotalol Hydrochloride)FDA LinkGeneric 09/2010
1	Indicators and Reagents (Reagents)IBA 05/2010
1	Anti-Arrhythmia AgentsIBA 10/2004

Therapy/Procedure

5	Renal Dialysis (Hemodialysis) 02/2022 - 01/2021
3	Therapeutics 04/2021 - 01/2021
2	Percutaneous Coronary Intervention 05/2013 - 01/2011
1	Length of Stay 01/2022
1	Ganglionectomy 03/2020
1	Spinal Anesthesia 09/2017